Biochemical monitoring of prostate cancer treated exclusively by radiotherapy: prognostic value of pretreatment PSA, PSA nadir and PSA half-life;Suivi biologique du cancer de la prostate traité par radiothérapie exclusive: valeur pronostique du PSA pré-thérapeutique, du PSA Nadir et de la demi-vie du PSA.

Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie

Volumn 12, Issue 3, 2002, Pages 421-428

  Chautard, Denis ^a   Cellier, Patrice ^a   Dalifard, Isabelle ^a   Pabot du Chatelard, Pierre ^a   Chaussis, François ^a   Vielle, Bruno ^a   Soret, Jean Yves ^a   Passagot, Jacques ^a   Courte, Claude ^a   Daver, Alain ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PREDICTION AND FORECASTING; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSTATE TUMOR; RETROSPECTIVE STUDY; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0036596342     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)